Synapse - Wiley Blackwell

Wiley Blackwell

SHERPA: Unknown

People

Herr
Motzer
Brennan
Shah
Danishefsky
Vickers
Russo
Shaha
Eastham
Scardino

Groups

Department of Medicine (1534)
Surgery (1246)
Solid Tumor Oncology Division (891)
Survivorship Research (826)
GSK Faculty (671)
Population Sciences Research Program (626)
Sloan Kettering Institute Faculty (612)
Department of Pathology and Laboratory Medicine (554)
Epidemiology and Biostatistics (493)
Center for Hematologic Malignancies (437)

Search Within

Results (4796)

Export to EndNote / Excel

Prognostic factors for progression-free survival (PFS), overall survival (OS), and long-term OS (LT-OS) with sunitinib in 1,059 patients, treated on clinical trials, with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Motzer, R. J.; Escudier, B.; Bukowski, R.; Rini, B. I.; Hutson, T. E.; Barrios, C. H.; Lin, X.; Fly, K.; Matczak, E.; Gore, M. E.
BJU International (2012)

Fulltext@MSK | Save

Real-world presurgical characteristics and postsurgical morbidity of 10,404 Americans undergoing nephrectomy because of renal tumors

Meeting Abstract

Lowrance, W.; Larson, S.; Asnis-Alibozek, A.; LaFrance, N.; Russo, P.; Divgi, C.
BJU International (2012)

Fulltext@MSK | Save

A pooled analysis of the efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Hutson, T. E.; Bukowski, R.; Rini, B. I.; Gore, M. E.; Larkin, J. M.; Figlin, R. A.; Barrios, C. H.; Escudier, B.; Lin, X.; Fly, K.; more...
BJU International (2012)

Fulltext@MSK | Save

Subgroup analysis of the phase 3 RECORD-1 trial of everolimus in patients with metastatic renal cell carcinoma: 1 versus 2 prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies

Meeting Abstract

Figlin, R. A.; Motzer, R.; Hutson, T. E.; Oudard, S.; Porta, C.; Grünwald, V.; Ravaud, A.; Panneerselvam, A.; Calvo, E.
BJU International (2012)

Fulltext@MSK | Save

Mdm2 and MdmX partner to regulate p53

Journal Article

Wang, X.; Jiang, X.
FEBS Letters (2012)

Fulltext@MSK | Save

A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid

Journal Article

Sharma, M.; Khan, H.; Thall, P. F.; Orlowski, R. Z.; Bassett, R. L. Jr; Shah, N.; Bashir, Q.; Parmar, S.; Wang, M.; Shah, J. J.; more...
Cancer (2012)

Fulltext@MSK | Save

BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α

Journal Article

Rodriguez, D. A.; Zamorano, S.; Lisbona, F.; Rojas-Rivera, D.; Urra, H.; Cubillos-Ruiz, J. R.; Armisen, R.; Henriquez, D. R.; Cheng, E. H.; Letek, M.; more...
EMBO Journal (2012)

Fulltext@MSK | Save

Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: Findings from a large national database